How Snapchat Wants to Win the 2016 Election
Snapchat is getting a lot of attention for its presidential ambitions.
In an effort to both appeal to the youth vote and bolster its events coverage built on a growing volume of video posted by its users, the app recently posted a job opening for a Content Analyst in Politics & News.
The new hire will curate photos and videos for the app’s “Our Story” curated events coverage of the presidential race and other news events. That stories feature has already proven to be a massive success. On average, Snapchat’s Our Stories draws around 20 million people in a 24-hour window, director of partnerships at Snapchat, Ben Schwerin, told Re/code. The three-day story in April about Coachella, the music festival, generated 40 million unique visitors.
Political events might not be draws on that same scale, but Snapchat apparently believes its massive influence with younger Americans could attract millions millennials to engage in the political process at a time when voter turnout is at its lowest levels since World War II. In the 2012 mid-term election, the national turnout rate was 35.9 percent. Of that, only 13 percent were between the ages of 18 and 29.
Related: Can ‘Project Lightning’ Give Twitter a Fresh Jolt?
Boasting more than 100 million daily users, Snapchat is valued at $16 billion — giving it the reach and the financial clout to become a force in 2016 campaign coverage. About 60 percent of U.S. smartphone users aged between 13 and 24 have used the app, according to The Financial Times. The largest demographic of users is between the ages of 18 and 24 (45 percent), followed by those between 25 and 34 (26 percent).
To capitalize on that user base, Snapchat recently hired former CNN political reporter Peter Hamby to oversee its expanding news team. Snapchat wants to promote content from debates, rallies, appearances and other election events and allow users to follow along. But this isn’t purely an experiment in civic participation. Candidates can pay for political ads to appear on the social media app.
The social media app has an ace up its sleeve to incentivize candidates to purchase ads. The app already has age-gating technology and a form of geographic targeting. Originally put into place to make sure underage kids wouldn’t see alcohol ads, the age gate could be used to reach only voting-age users. The geographic targeting allows Our Stories to only be viewable by people in the same city or area, so politicians could target specific areas, especially ones in a tight race.
Snapchat, best known as the service that allows users to send disappearing photos, claims that ads inserted into “Our Stories” have an advantage over other social media advertisements because they leave more lasting impressions.
If campaigns buy into that and turn to Snapchat as a way to connect with a hard-to-reach demographic, the social media company could be the big winner in the 2016 election.
Chart of the Day: High Deductible Blues
The higher the deductible in your health insurance plan, the less happy you probably are with it. That’s according to a new report on employer-sponsored health insurance from the Kaiser Family Foundation and the Los Angeles Times.
Chart of the Day: Tax Cuts and the Missing Capex Boom
Despite the Republican tax overhaul, businesses aren’t significantly increasing their capital expenditures. “The federal government will have to borrow an added $1 trillion through 2027 to pay for the corporate tax breaks,” says Bloomberg’s Mark Whitehouse. “So far, it’s hard to see what the country is getting in return.”
Chart of the Day: 2019’s Lobbying Leaders
Roll Call reports that trade, infrastructure and health care issues including prescription drug prices “dominated the lobbying agendas of some of the biggest spenders on K Street early this year.” Here’s Roll Call’s look at the top lobbying spenders so far this year:
Can You Fix Social Security? A New Tool Lets You Try
The Congressional Budget Office released an interactive tool Wednesday that shows how some widely discussed policy changes would affect the long-run financial health of the Social Security system.
“This interactive tool allows the user to explore seven policy options that could be used to improve the Social Security program’s finances and delay the trust funds’ exhaustion,” CBO said. “Four options would reduce benefits, and three options would increase payroll taxes. The tool allows for any combination of those options. It also lets the user change implementation dates and choose whether to show scheduled or payable benefits. … The tool also shows the impact of the options on different groups of people.”
Click here to view the interactive tool on the CBO website.
Why Prescription Drug Prices Keep Rising – and 3 Ways to Bring Them Down
Prescription drug prices have been rising at a blistering rate over the last few decades. Between 1980 and 2016, overall spending on prescription drugs rose from about $12 billion to roughly $330 billion, while its share of total health care spending doubled, from 5% to 10%.
Although lawmakers have shown renewed interest in addressing the problem, with pharmaceutical CEOs testifying before the Senate Finance Committee in February and pharmacy benefit managers (PBMS) scheduled to do so this week, no comprehensive plan to halt the relentless increase in prices has been proposed, let alone agreed upon.
Robin Feldman, a professor at the University of California Hastings College of Law, takes a look at the drug pricing system in a new book, “Drugs, Money and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices.” In a recent conversation with Bloomberg’s Joe Nocera, Feldman said that one of the key drivers of rising prices is the ongoing effort of pharmaceutical companies to maintain control of the market.
Fearing competition from lower-cost generics, drugmakers began over the last 10 or 15 years to focus on innovations “outside of the lab,” Feldman said. These innovations include paying PBMs to reduce competition from generics; creating complex systems of rebates to PBMs, hospitals and doctors to maintain high prices; and gaming the patent system to extend monopoly pricing power.
Feldman’s research on the dynamics of the drug market led her to formulate three general solutions for the problem of ever-rising prices:
1) Transparency: The current system thrives on secret deals between drug companies and middlemen. Transparency “lets competitors figure out how to compete and it lets regulators see where the bad behaviors occur,” Feldman says.
2) Patent limitations: Drugmakers have become experts at extending patents on existing drugs, often by making minor modifications in formulation, dosage or delivery. Feldman says that 78% of drugs getting new patents are actually old drugs gaining another round of protection, and thus another round of production and pricing exclusivity. A “one-and-done” patent system would eliminate this increasingly common strategy.
3) Simplification: Feldman says that “complexity breeds opportunity,” and warns that the U.S. “drug price system is so complex that the gaming opportunities are endless.” While “ruthless simplification” of regulatory rules and approval systems could help eliminate some of those opportunities, Feldman says that the U.S. doesn’t seem to be moving in this direction.
Read the full interview at Bloomberg News.